Eledon Pharmaceuticals Investor Relations Material
Latest events
Study Update
Eledon Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Eledon Pharmaceuticals Inc
Access all reports
Eledon Pharmaceuticals, Inc. (Eledon) is an ophthalmic biopharmaceutical company specializing in the development of medicines for patients with vision loss associated with autoimmune disease, such as dry eye disease, as well as transplant patients who need a corneal transplant. The Company is focused on developing medicines to treat dry eye disease and prevent corneal scarring in corneal transplant patients.
Latest articles
Remembering Daniel Kahneman: Transforming Psychology and Economics
Explore Daniel Kahneman's legacy in psychology and economics, highlighting his impact on decision-making and behavioral economics.
28 Mar 2024
Deere & Company: Shaping Agriculture & Construction Since 1837
Exploring Deere & Company: A global leader in agriculture & construction equipment since 1837.
28 Mar 2024
Jane Fraser: First Female Leader of a Major Wall Street Bank
Discover the journey of Jane Fraser, CEO of Citigroup and the first female leader of a major Wall Street bank.
28 Mar 2024
Ticker symbol
Country
🇺🇸 United States